Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRTA
11101
Strata Critical Medical Inc
SRTA
$528M
| $84.4K | ﹤0.01% |
28,697
-38,527
| -57% | -$123K |
|
11102
PUT
NovaGold Resources
NG
$3.84B
| $83.6K | ﹤0.01% |
20,400
-357,400
| -95% | -$1.52M |
|
11103
Santander
BSBR
$43.5B
| $83.4K | ﹤0.01% |
+15,862
| New | +$84.5K |
|
11104
PUT
Oportun Financial
OPRT
$338M
| $83.2K | ﹤0.01% |
29,600
+4,300
| +17% | +$12.5K |
|
11105
PUT
Aterian
ATER
$7.03M
| $82.9K | ﹤0.01% |
28,800
+1,700
| +6% | +$5.08K |
|
11106
Gaia
GAIA
$39.4M
| $82.9K | ﹤0.01% |
+17,025
| New | +$79.5K |
|
11107
PUT
Cato Corp
CATO
$52.9M
| $82.8K | ﹤0.01% |
+16,600
| New | +$81.8K |
|
|
EMKR
11108
DELISTED
Emcore Corp
EMKR
| $82.8K | ﹤0.01% |
+37,468
| New | +$42.8K |
|
11109
Citius Pharmaceuticals
CTXR
$16.5M
| $82.6K | ﹤0.01% |
6,603
-19,019
| -74% | -$320K |
|
11110
CarParts.com
PRTS
$55.9M
| $81.9K | ﹤0.01% |
9,042
-26,957
| -75% | -$255K |
|
|
FRGE
11111
DELISTED
Forge Global Holdings
FRGE
| $81.5K | ﹤0.01% |
4,148
-5,656
| -58% | -$118K |
|
|
XNET
11112
Xunlei
XNET
$319M
| $81.5K | ﹤0.01% |
44,048
+5,520
| +14% | +$9.1K |
|
|
ACP
11113
abrdn Income Credit Strategies Fund
ACP
$642M
| $81.3K | ﹤0.01% |
+12,282
| New | +$80.1K |
|
|
HFRO
11114
Highland Opportunities and Income Fund
HFRO
$409M
| $81.2K | ﹤0.01% |
+13,252
| New | +$80.7K |
|
11115
Phunware
PHUN
$42.8M
| $81.2K | ﹤0.01% |
23,728
+516
| +2% | +$2.09K |
|
11116
CALL
loanDepot
LDI
$325M
| $81.1K | ﹤0.01% |
29,700
+15,800
| +114% | +$37.3K |
|
11117
CALL
Lesaka Technologies
LSAK
$396M
| $81K | ﹤0.01% |
16,200
-14,000
| -46% | -$66.4K |
|
11118
Lantern Pharma
LTRN
$26.5M
| $80.3K | ﹤0.01% |
21,881
-37,878
| -63% | -$156K |
|
11119
CALL
Newegg Commerce
NEGG
$350M
| $80.1K | ﹤0.01% |
5,415
+3,940
| +267% | +$67.4K |
|
|
VXRT
11120
PUT
DELISTED
Vaxart
VXRT
| $80.1K | ﹤0.01% |
94,200
-59,000
| -39% | -$45.1K |
|
|
LVTX
11121
DELISTED
LAVA Therapeutics
LVTX
| $80K | ﹤0.01% |
+48,205
| New | +$88.2K |
|
11122
CALL
Heron Therapeutics
HRTX
$62M
| $80K | ﹤0.01% |
40,200
+1,900
| +5% | +$4.54K |
|
|
VXRT
11123
CALL
DELISTED
Vaxart
VXRT
| $80K | ﹤0.01% |
94,100
+79,800
| +558% | +$61K |
|
|
PVL
11124
Permianville Royalty Trust
PVL
$60.7M
| $79.8K | ﹤0.01% |
49,244
+1,000
| +2% | +$1.57K |
|
11125
KVH Industries
KVHI
$136M
| $79.7K | ﹤0.01% |
16,503
-34,192
| -67% | -$156K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.